Kuvatris Therapeutics Inc PXMD
$0.00
Last Updated: Aug 20, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
PXMD Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Kuvatris Therapeutics Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Kuvatris Therapeutics Inc. Stock Analysis PXMD
United States Health Care Nano Cap PaxMedica, Inc. is a clinical stage biopharmaceutical company. The company is headquartered in Tarrytown, New York and currently employs 6 full-time employees. The company went IPO on 2022-08-19. The company is focusing on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, ranging from neurodevelopmental disorders, including autism spectrum disorder (ASD), to neurodegenerative disorders, such as Fragile X Tremor Ataxia Syndrome (FXTAS) and post-viral Myalgic Encephalomyelitis/Chronic c Syndrome (ME/CFS), a debilitating physical and cognitive disorder believed to be viral in origin and with rising incidence globally due to the long-term effects of SARS-CoV-2 (COVID-19). Its lead program, PAX-101 is an intravenous formulation of suramin in the treatment of ASD and the advancement of the clinical understanding of using that agent against other disorders: fragile X syndrome (FXS), FXTAS, ME/CFS and Long COVID-19 Syndrome (LCS), a clinical diagnosis in individuals who have been previously infected with COVID-19.
Kuvatris Therapeutics Inc (PXMD) Chart
Financial Metrics & Statements of Kuvatris Therapeutics Inc (PXMD)
FAQ's for Kuvatris Therapeutics Inc (PXMD)
- As of August 2026, Kuvatris Therapeutics Inc PXMD is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Kuvatris Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Kuvatris Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Kuvatris Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Kuvatris Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Kuvatris Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Kuvatris Therapeutics Inc (PXMD)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
